The 5-year survival rate for malignant retroperitoneal tumors is 14.5%.
腹膜后恶性肿瘤切除术后，5年生存率为14．5％。
Ovarian cancer is rare in women under 30 but the 5-year survival rate for that age group was 79 percent.
卵巢癌鲜见于30岁以下的女性，但这一年龄段患者的5年存活率高达79%。
The 5 year survival rate was 76.5 % in chemo-radiotherapy group and 50 % in only radiotherapy group (P<0.05).
放疗同步化疗组5年生存率为76.5%，单纯放疗组5年生存率为50%，两组差异有显著性（P<0.05）。
The American cancer Society says the five-year survival rate for pancreatic cancer patients is about 5 percent.
在美国有37680名患者被查出胰腺癌，其中34290死于胰腺癌。美国癌症协会称过去5年内这种癌症病人的存活率约5%。
Each five-year survival rate after surgery varies depending on the nature of cancer and may be found sooner or later.
手术后五年存活率各人不一，端看肿瘤的性质及发现的早晚而定。
Ampullary cancer resection rate in more than 75%, 5-year survival rate after surgery than high-pancreatic head cancer.
壶腹癌的切除率在75%以上，术后5年存活率较胰头癌高。
Results The 3-year survival rate was better in patients without giant tumor bulk than that with giant tumor bulk(P<0.01).
结果巨大肿块组3年生存率明显好于无巨大肿块组（P<0.01）；
Results 9 cases of cerebellar medulloblastoma undergoing radical resection survived, with the 5-year survival rate of 100%.
结果“根治性”切除术后9例儿童小脑髓母细胞瘤患儿均存活，5年生存率为10 0 %。
The 3 year survival rate for radical resection group was 61 1% and higher than that of 18 2% for palliative excision group( P< 0 01).
根治手术病例3年生存率为6 1 1% ，姑息手术病例3年生存率为18 2 % ，两组比较差异有非常显著性意义（P< 0 0 1）。
Objective Retrospectively analyzed the 3-year survival rate and the factors of low-grade glioma treated by postoperative radiotherapy.
目的回顾性分析低分级脑胶质瘤术后放疗的3年生存率及其影响因素。
The result indicated that the cases with a high mast cell count show a significant better 5-year survival rate than those with a low count.
结果显示：肥大细胞高计数组患者的五年生存率明显高于低计数组。
RESULTS: The candidates' overall 3-year survival rate and recurrence-free survival rate were 67% and 70% after transplantation, respectively.
结果：在移植后，候选人全部3年存活率和无肿瘤复发存活率分别为67％、70％。
Secondary endpoints included objective response rate, one-year survival rate, overall survival, PFS assessment by chemotherapy type and safety.
二级终点包含了目标反应率，一年生存期，总生存率，化疗类型和安全性PFS评估。
These data implied that the use of high-dose steroids and antibiotics can lower the occurrence of cholangitis and elevate 2 year survival rate.
术后大剂量应用激素和抗生素疗法明显降低早期急性胆管炎发生率，提高术后2年生存率。
Conclusions: early diagnosis and early treatment is the key measure to improve the 5-year survival rate of young patients with colorectal cancer.
结论：早期诊断、早期治疗是提高青年人大肠癌5年生存率的关键。
The five-year survival rate for melanoma is about 98 percent if detected early but can be as low as 15 percent when detected at an advanced stage.
如果诊断及时，98%的病人能够活5年以上，但如果在晚期才诊断出黑色素瘤，这个数字就降至15%。
Results:According to the 5-year survival rate and 10-year survival rate, the clinical stage influence the prognosis of ovarian granulosa cell tumor.
结果：根据随访了解5年和10年存活率，表明临床期别与预后呈显著相关性。
The study found that the one-year survival rate was 89 percent for those who got older blood, but nearly 93 percent for patients who got fresher blood.
研究发现一年后病人的存活率在输入存放时间较长血液的病人组中是89%，在另一组中93%。
Objective: to study the 5-year survival rate and main factors that influence the survival time of the patients with Non-small cell Lung cancer (NSCLC).
目的：了解非小细胞肺癌(NSCLC)患者术后5年生存率及影响非小细胞肺癌患者5年生存的因素。
The five-year survival rate, a key indicator for cancer remission, is less than 25 percent among Chinese patients. In western countries, the number is 68.
五年存活率(缓解癌症的关键指标)在中国患者身上低于25%，而在西方国家，该比例是68%。
Chemotherapy with VBP and regimen concurrent radiation therapy may improve the3-year survival rate of advanced cervical cancer, the toxicity are tolerable.
放疗同时配合VBP化疗方案治疗宫颈癌，有利于提高中、晚期宫颈癌的3年生存率，其毒副反应可以耐受。
Methods 146 patients were divided into treated and control group. The peritoneal and hepatic recurrence and 3 year survival rate of each group were analyzed.
方法对146例进展期胃癌病人分组行腹腔热低渗液灌注及动脉插管化疗，并对其腹腔转移率、肝转移率及3年生存率对照研究。
There are four stages in the course of the disease: the 5-year survival rate of stage I CRC is about 90%, stage II is about 60-80%, stage III is about 30-60 %.
就其肿瘤分期而言，第一期的五年存活率约为90%，第二期的五年存活率约为60-80%，第三期的五年存活率则约为30-60%，若是有远端转移的病患，则其五年存活率却只有5%；
The differences of 5-year survival rate between the post-operative comprehensive treatment group and only operation group had statistical significance (P<0.05).
手术后合并化疗的综合治疗组和单纯手术治疗组的5年生存率差异有统计学意义（P＜0.05）。
The 5 year survival rate in local irradiation was 54.5%, in irregular large fields irradiation may be enhanced to 88.9% for the patients with Hodgkin's lymphoma.
霍奇金淋巴瘤采用局部野照射后5年生存率为54.5%，采用大面积不规则野照射可以提高到88.9%。
To the later period breast cancer patient, after passing through the chemotherapy and the endocrine treatment, 5 year survival rate still might achieve above 25%.
对晚期的乳腺癌患者，经过化疗和内分泌治疗后，5年生存率仍可达到25%以上。
With current therapies of OS, such as extensive surgical excision, radiotherapy and neoadjuvant chemotherapy, five-year survival rate has increased up to 50%-60%.
随着骨肉瘤治疗手段的进展，如扩大切除术、放疗和新辅助化疗，其5年生存率已经增加到50～60%。
With current therapies of OS, such as extensive surgical excision, radiotherapy and neoadjuvant chemotherapy, five-year survival rate has increased up to 50%-60%.
随着骨肉瘤治疗手段的进展，如扩大切除术、放疗和新辅助化疗，其5年生存率已经增加到50～60%。
应用推荐